Robert A. Long
Robert A. Long publishes mostly in Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine, on topics such as Synthesis and Characterization of Heterocyclic Compounds, Synthesis and Reactions of Organic Compounds and Synthesis and biological activity.
- World rank
- #4,011,416 of 7,710,434 ranked researchers
- Rank in United States
- #1,093,629 of 1,627,098
- Works
- 90
- Citations
- 1.1k
- Citations per work
- 12.0
What does Robert A. Long research?
Robert A. Long's work is mostly in Chemistry (26%), Biochemistry, Genetics and Molecular Biology (15%), Medicine (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4650.9%
- Physical Sciences2326.0%
- Chemistry2326.0%
- Life Sciences1718.6%
- Health Sciences44.5%
- Medicine44.5%
- 1Organic Chemistry26% of their works
- 2Molecular Biology9% of their works
- 3Cardiology and Cardiovascular Medicine4% of their works
- 4Genetics4% of their works
- 5Animal Science and Zoology4% of their works
- 6Cell Biology2% of their works
Research topics
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Reactions of Organic Compounds
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Genetic and phenotypic traits in livestock
- Cardiac electrophysiology and arrhythmias
- DNA and Nucleic Acid Chemistry
- Biochemical and Molecular Research
Which keywords describe Robert A. Long's research?
The keywords of their largest research topics: Synthesis, Heterocycles, Biological Evaluation, Catalyst, Antimicrobial, Heterocyclic Compounds, Medicinal Chemistry and Triazines.
- Nucleotide Metabolism
- Enzyme Regulation
- Plant Breeding
- Genomic Selection
- Vascular Targeting Agents
- Quinoxaline
- Oxazolones
- Triazines
- Heterocyclic Compounds
- Catalyst
- Heterocycles
- Synthesis
- Biological Evaluation
- Antimicrobial
- Medicinal Chemistry
- Imidazoles
- Antimicrobial Activity
- Tubulin Inhibitors
- Arrhythmias
- Long-QT Syndrome
- DNA Structure
- G-Quadruplexes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Synthesis333 topics
- Heterocycles252 topics
- Biological Evaluation242 topics
- Catalyst172 topics
- Antimicrobial161 topic
- Heterocyclic Compounds162 topics
- Medicinal Chemistry162 topics
- Triazines161 topic
- Imidazoles91 topic
- Oxazolones91 topic
- Antimicrobial Activity81 topic
- Quinoxaline81 topic
- Tubulin Inhibitors81 topic
- Vascular Targeting Agents81 topic
- Arrhythmias51 topic
- Genomic Selection51 topic
- Long-QT Syndrome51 topic
- Plant Breeding51 topic
- DNA Structure41 topic
- Enzyme Regulation41 topic
- G-Quadruplexes41 topic
- Nucleotide Metabolism41 topic
Where does Robert A. Long work?
Robert A. Long's main affiliation in the publication record is Burroughs Wellcome Fund, United States.
How many publications and citations does Robert A. Long have?
OpenAlex counts 90 works and 1,080 citations for Robert A. Long, an h-index of 17, ranking #4,011,416 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Robert A. Long
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert A. Long. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.